Sunday, 23 February 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 23 February 2025
News

Pharma sells for 66% below peak

Posted 21 February 2025 PM

ASX-listed Mayne Pharma announced a deal today to be acquired for $672 million by US pharma Cosette.

Cosette has agreed to pay $7.40 per share in cash, a 36.78 per cent premium over yesterday's closing price, and a 42 per cent premium to the 30-day volume weighted average price. However, it's a far cry from the roughly $2 billion market cap that represented the stock's peak in 2016.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (24)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (2)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.